Hologic Going Private in $18.3 Billion Deal with Blackstone and TPG (Minority Investment from ADIA and GIC)
October 22, 2025
Hologic, a women’s health company, entered into a definitive agreement to be acquired for an enterprise value of approximately $18.3 billion by funds managed by Blackstone and TPG. Under the terms, Hologic stockholders will receive $76 per share in cash plus a contingent value right worth up to an additional $3 per share tied to Breast Health revenue milestones.
- Buyers
- Blackstone, TPG, Abu Dhabi Investment Authority (ADIA), GIC
- Targets
- Hologic
- Industry
- Medical Devices
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Hologic Acquires Gynesonics
January 6, 2025
Medical Devices
Hologic, Inc. completed its previously announced acquisition of Gynesonics, a privately held medical device company focused on minimally invasive solutions for women’s health, for about $350 million. Gynesonics develops the Sonata System for diagnostic intrauterine imaging and incision-less transcervical treatment of certain symptomatic uterine fibroids.
-
Hologic Acquires Bolder Surgical for Approximately $160 Million
October 14, 2021
Healthcare Services
Hologic, Inc. has completed its previously announced acquisition of Bolder Surgical, a privately held U.S. provider of advanced energy vessel sealing surgical devices, for approximately $160 million. The deal expands Hologic’s surgical portfolio with laparoscopic vessel sealing, dividing and dissection tools and enables broader use of Bolder’s devices by OB/GYN specialists.
-
TPG Capital to Acquire Convey Health Solutions in ~$1.1B Deal
June 22, 2022
Healthcare Services
TPG Capital, the private equity platform of TPG, announced it will acquire Convey Health Solutions Holdings in a definitive merger agreement valued at approximately $1.1 billion. Under the terms, TPG Capital will buy all shares not already owned by it or certain management and director shareholders for $10.50 per share in cash, with closing expected in the second half of 2022.
-
Novartis Acquires Anthos Therapeutics for Up to $3.1B
February 11, 2025
Pharmaceuticals
Blackstone Life Sciences and Anthos Therapeutics announced that Novartis will acquire Anthos for up to $3.1 billion, including a $925 million upfront payment to Anthos shareholders. The deal is expected to close in the first half of 2025, subject to customary closing conditions and regulatory approvals. Novartis later completed the acquisition, valuing the transaction at up to $3.1 billion with the $925 million upfront payment.
-
Hologic, Inc. Acquires Mobidiag Oy
June 17, 2021
Medical Devices
Hologic, Inc. has completed the acquisition of Mobidiag Oy, a Finnish developer of near‑patient molecular diagnostic instruments and tests, for approximately $808 million. The deal expands Hologic's diagnostics capabilities by adding Mobidiag's Amplidiag and Novodiag platforms for rapid, multiplexed acute‑care testing and broadens Hologic's global diagnostics footprint.
-
Hellman & Friedman and Bain Capital Acquire athenahealth for $17 Billion
February 15, 2022
Cloud & SaaS
Affiliates of Hellman & Friedman and Bain Capital completed the $17 billion acquisition of athenahealth from Veritas Capital and Evergreen Coast Capital. The deal brings in additional coinvestors (including an affiliate of GIC and a subsidiary of ADIA) while Veritas and Evergreen each retain minority investments as the buyers look to scale athenahealth's cloud-based healthcare SaaS platform.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.